Barclays’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.9M | Buy |
+125,500
| New | +$63.5M | 0.01% | 673 |
|
|
2025
Q4 | – | Sell |
-175,000
| Closed | -$78.3M | – | 5452 |
|
|
2025
Q3 | $78.3M | Buy |
+175,000
| New | +$84M | 0.02% | 586 |
|
|
2025
Q1 | – | Sell |
-50,400
| Closed | -$26.3M | – | 5394 |
|
|
2024
Q4 | $26.3M | Hold |
50,400
| – | – | 0.01% | 966 |
|
|
2024
Q3 | $24.8M | Buy |
+50,400
| New | +$23.5M | 0.01% | 962 |
|
|
2024
Q2 | – | Sell |
-24,300
| Closed | -$9.7M | – | 5086 |
|
|
2024
Q1 | $9.7M | Buy |
+24,300
| New | +$9.18M | ﹤0.01% | 1413 |
|
|
2023
Q1 | – | Sell |
-38,700
| Closed | -$10.3M | – | 5208 |
|
|
2022
Q4 | $10.3M | Buy |
+38,700
| New | +$9.44M | ﹤0.01% | 1194 |
|
|
2021
Q1 | – | Sell |
-7,200
| Closed | -$1.96M | – | 4945 |
|
|
2020
Q4 | $1.96M | Sell |
7,200
-15,000
| -68% | -$3.72M | ﹤0.01% | 2250 |
|
|
2020
Q3 | $5.25M | Sell |
22,200
-15,900
| -42% | -$3.57M | ﹤0.01% | 1363 |
|
|
2020
Q2 | $7.24M | Sell |
38,100
-84,300
| -69% | -$15.1M | 0.01% | 1136 |
|
|
2020
Q1 | $20.2M | Sell |
122,400
-27,000
| -18% | -$4.95M | 0.02% | 638 |
|
|
2019
Q4 | $29.4M | Sell |
149,400
-89,100
| -37% | -$16.7M | 0.02% | 745 |
|
|
2019
Q3 | $42.9M | Buy |
238,500
+30,000
| +14% | +$5.19M | 0.03% | 520 |
|
|
2019
Q2 | $36.5M | Buy |
208,500
+71,100
| +52% | +$12.2M | 0.02% | 612 |
|
|
2019
Q1 | $26.1M | Sell |
137,400
-7,800
| -5% | -$1.39M | 0.02% | 707 |
|
|
2018
Q4 | $23.2M | Sell |
145,200
-42,900
| -23% | -$7.27M | 0.02% | 681 |
|
|
2018
Q3 | $36M | Buy |
188,100
+53,400
| +40% | +$9.48M | 0.02% | 556 |
|
|
2018
Q2 | $21.5M | Buy |
134,700
+7,200
| +6% | +$1.1M | 0.02% | 754 |
|
|
2018
Q1 | $17.5M | Sell |
127,500
-44,400
| -26% | -$6.2M | 0.01% | 911 |
|
|
2017
Q4 | $20.9M | Sell |
171,900
-39,600
| -19% | -$4.96M | 0.02% | 783 |
|
|
2017
Q3 | $24.6M | Buy |
211,500
+54,000
| +34% | +$5.88M | 0.03% | 578 |
|
|
2017
Q2 | $16.4M | Sell |
157,500
-20,700
| -12% | -$1.99M | 0.02% | 705 |
|
|
2017
Q1 | $15.2M | Sell |
178,200
-126,900
| -42% | -$10M | 0.02% | 671 |
|
|
2016
Q4 | $21.5M | Buy |
305,100
+135,000
| +79% | +$9.93M | 0.02% | 564 |
|
|
2016
Q3 | $13.7M | Buy |
170,100
+63,000
| +59% | +$4.82M | 0.02% | 702 |
|
|
2016
Q2 | $7.87M | Sell |
107,100
-16,200
| -13% | -$1.14M | 0.01% | 981 |
|
|
2016
Q1 | $8.23M | Sell |
123,300
-170,100
| -58% | -$10.5M | 0.01% | 866 |
|
|
2015
Q4 | $17.8M | Sell |
293,400
-212,400
| -42% | -$11.9M | 0.02% | 624 |
|
|
2015
Q3 | $25.8M | Buy |
505,800
+98,100
| +24% | +$5.56M | 0.03% | 483 |
|
|
2015
Q2 | $21.9M | Buy |
407,700
+182,700
| +81% | +$10.2M | 0.02% | 610 |
|
|
2015
Q1 | $12.6M | Buy |
225,000
+6,300
| +3% | +$357K | 0.01% | 942 |
|
|
2014
Q4 | $12.8M | Sell |
218,700
-123,300
| -36% | -$6.87M | 0.01% | 1022 |
|
|
2014
Q3 | $17.5M | Buy |
342,000
+47,700
| +16% | +$2.37M | 0.02% | 800 |
|
|
2014
Q2 | $13.4M | Sell |
294,300
-582,300
| -66% | -$25.7M | 0.01% | 952 |
|
|
2014
Q1 | $42.6M | Sell |
876,600
-418,500
| -32% | -$19.7M | 0.05% | 349 |
|
|
2013
Q4 | $55.3M | Buy |
1,295,100
+771,300
| +147% | +$32.5M | 0.06% | 301 |
|
|
2013
Q3 | $21.9M | Sell |
523,800
-7,200
| -1% | -$318K | 0.03% | 624 |
|
|
2013
Q2 | $29.9M | Buy |
+531,000
| New | +$29.3M | 0.04% | 441 |
|
Other funds holding ISRG
VCM
VPM
Barclays's ISRG Position: Q1 2026 in Review
Barclays reduced its Intuitive Surgical (ISRG) stake by 29% in Q1 2026, selling an estimated $325M and leaving 1,592,310 shares worth $734M. The position accounts for 0.18% of the portfolio, ranked #86.
Barclays first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.27B in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Barclays held 1,592,310 shares of Intuitive Surgical worth $734M as of Q1 2026.
- Barclays sold 642,570 Intuitive Surgical shares in Q1 2026, an estimated $325M.
- Intuitive Surgical made up 0.18% of Barclays's portfolio in Q1 2026, its #86 holding.
- Barclays first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Intuitive Surgical position peaked at $1.27B in Q4 2025.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.